Literature DB >> 11257774

Surgical management of multidrug-resistant tuberculosis.

S Sasano1, H Yamamoto, T Otsuka, A Fujita, T Onuki, S Nitta.   

Abstract

We report surgical resections in 3 patients with active multidrug-resistant tuberculosis. All cases involved strains of Mycobacterium tuberculosis resistant to at least isoniazid and rifampin and patients who were poor candidates for medical therapy alone. We conducted pulmonary resections (partial resection in case 1, lobectomy in case 2, and segmentectomy in case 3). The optimum multiple-drug regimen, based on drug susceptibility studies, was used preoperatively and postoperatively. In all cases, sputum smears and cultures yielded negative results postoperatively, and continue to be negative for Mycobacterium tuberculosis to date. It is recommended that, if localized disease is present and medical treatment is likely to fail, pulmonary resection be conducted for multidrug-resistant Mycobacterium tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257774     DOI: 10.1007/bf02912135

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  10 in total

Review 1.  Surgical indications for treatment of pulmonary tuberculosis.

Authors:  J Freixinet
Journal:  World J Surg       Date:  1997-06       Impact factor: 3.352

Review 2.  Surgery in the treatment of multidrug-resistant tuberculosis.

Authors:  M Pomerantz; J M Brown
Journal:  Clin Chest Med       Date:  1997-03       Impact factor: 2.878

3.  Trends in drug-resistant tuberculosis in the United States, 1993-1996.

Authors:  M Moore; I M Onorato; E McCray; K G Castro
Journal:  JAMA       Date:  1997-09-10       Impact factor: 56.272

4.  Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

Authors:  M M Park; A L Davis; N W Schluger; H Cohen; W N Rom
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

5.  Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis.

Authors:  S W Sung; C H Kang; Y T Kim; S K Han; Y S Shim; J H Kim
Journal:  Eur J Cardiothorac Surg       Date:  1999-08       Impact factor: 4.191

6.  Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections.

Authors:  M Pomerantz; L Madsen; M Goble; M Iseman
Journal:  Ann Thorac Surg       Date:  1991-11       Impact factor: 4.330

7.  Improved outcomes for patients with multidrug-resistant tuberculosis.

Authors:  G S Turett; E E Telzak; L V Torian; S Blum; D Alland; I Weisfuse; B A Fazal
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

8.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

9.  Multidrug-resistant tuberculosis in patients without HIV infection.

Authors:  E E Telzak; K Sepkowitz; P Alpert; S Mannheimer; F Medard; W el-Sadr; S Blum; A Gagliardi; N Salomon; G Turett
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

10.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.

Authors:  M Goble; M D Iseman; L A Madsen; D Waite; L Ackerson; C R Horsburgh
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.